Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2000
08/24/2000CA2362330A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000CA2362306A1 Chemical compounds
08/24/2000CA2362300A1 Human lipid-associated proteins
08/24/2000CA2362290A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000CA2328877A1 Composition for treatment of external secretion disorders except hypolacrimation
08/23/2000EP1029869A1 Endothelin converting enzyme inhibitors
08/23/2000EP1029054A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
08/23/2000EP1028977A2 Bifidus stimulating peptides
08/23/2000EP1028975A1 Artemin, a novel neurotrophic factor
08/23/2000EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists
08/23/2000EP1028956A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
08/23/2000EP1028954A1 Substituted imidazoles useful in the treatment of inflammatory diseases
08/23/2000EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
08/23/2000EP1028947A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028729A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds
08/23/2000EP0959872A4 Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
08/23/2000EP0821668B1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/23/2000EP0711289B1 Piperazine compounds used in therapy
08/23/2000EP0674642B1 Pyrazolopyrimidines as crf antagonists
08/23/2000CN1264382A Novel compounds
08/23/2000CN1264381A 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
08/23/2000CN1264378A Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors
08/23/2000CN1264307A Method of enhancing function of upper gastrointestinal tract
08/23/2000CN1264306A Method for treatment of diarrhea disease and removing special bacterial population
08/23/2000CN1264305A Oral care composition comprising bacillus pullulanase and dextranase
08/23/2000CN1263775A Chinese patent medicine 'Weichangan'
08/23/2000CN1055700C Therapeutic peptide derivatives
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107345 Antidepressant; psychological disorders
08/22/2000US6107334 Dietary control of arachidonic acid metabolism
08/22/2000US6107324 5-HT2A receptor inverse agonists
08/22/2000US6107310 Heteroarylcarboxamide derivatives for treating CNS disorders
08/22/2000US6107307 Psychological disorders
08/22/2000US6107305 Antiproferative agent, antiinflammatory agents
08/22/2000US6107300 Arylamino fused pyrimidines
08/22/2000US6107294 Nervous system and psychological disorders
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6107282 Treatment of C. difficile toxin B associated conditions
08/22/2000US6107075 Human elastase IV
08/22/2000US6107028 Prevention of viral replication or expression; insertion of a expression vector coding ribonucleic acid preferential proteolytic enzyme into cells infected with virus
08/22/2000US6107027 Supression of viral gene expression in cells; transducing cells with a adenovirus vector which codes a protein which has preferential proteolytic activity for ribonucleic acids
08/22/2000US6106871 Feeding ration of rumen protected choline to dairy cattle
08/22/2000US6106864 Pharmaceutical formulations containing darifenacin
08/22/2000US6106830 Methods for the treatment of apoptosis-related diseases by batroxobin
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these
08/22/2000CA2001754C Glucan dietary additives
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047581A1 Therapeutic nucleoside compound
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047575A1 Pyrrole derivatives and cell death inhibitors
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047565A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047284A2 Novel use of orexin receptor antagonists
08/17/2000WO2000047243A2 Pancreatic ductal trophic factors, uses and composition related thereto
08/17/2000WO2000047231A2 Novel antisense inhibition of rad51
08/17/2000WO2000047208A1 A transdermal composition of an antivomiting agent and a preparation containing the same
08/17/2000WO2000047198A2 Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
08/17/2000WO2000047196A2 Use of statins for treating viral infections
08/17/2000WO2000047195A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000047174A1 Compositions for controlling bacterial colonization
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000WO2000014263A3 Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
08/17/2000WO2000014262A9 Methylation of plasmid vectors
08/17/2000WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
08/17/2000CA2367575A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000CA2363088A1 Methods for treating viral infections
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2362109A1 Novel antisense inhibition of rad51
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/17/2000CA2359660A1 16-hydroxyestratrienes as selective estrogens
08/16/2000EP1027892A2 Azithromycin combination for emesis control in dogs
08/16/2000EP1027891A2 Neuropeptide y antagonists
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027351A1 Phenanthroline derivatives
08/16/2000EP1027342A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
08/16/2000EP1027336A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
08/16/2000EP1027332A1 Novel lactam metalloprotease inhibitors
08/16/2000EP1027325A2 Lipophilic diesters of chelating agents
08/16/2000EP1027064A1 Method for removing undesirable toxic alkaloids from plants or vegetable preparations
08/16/2000EP1027049A1 Intranasal formulation containing scopolamine and method of treating motion sickness
08/16/2000EP1027046A1 Antagonists of gonadotropin releasing hormone
08/16/2000EP1027036A2 Taste masked formulations
08/16/2000EP0707481B1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents
08/16/2000CN1263528A N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists
1 ... 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 ... 1258